ClinVar Miner

Submissions for variant NM_000090.4(COL3A1):c.3460dup (p.Ser1154fs)

dbSNP: rs2153503975
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001925950 SCV002185551 pathogenic Ehlers-Danlos syndrome, type 4 2022-09-29 criteria provided, single submitter clinical testing This variant has not been reported in the literature in individuals affected with COL3A1-related conditions. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1413452). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser1154Lysfs*15) in the COL3A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL3A1 are known to be pathogenic (PMID: 24922459).
Color Diagnostics, LLC DBA Color Health RCV003528344 SCV004363033 pathogenic Familial thoracic aortic aneurysm and aortic dissection 2023-07-06 criteria provided, single submitter clinical testing This variant inserts 1 nucleotide in exon 47 of the COL3A1 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, this variant has not been reported in individuals affected with COL3A1-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of COL3A1 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.
All of Us Research Program, National Institutes of Health RCV001925950 SCV004828020 pathogenic Ehlers-Danlos syndrome, type 4 2023-08-28 criteria provided, single submitter clinical testing This variant inserts 1 nucleotide in exon 47 of the COL3A1 gene, creating a frameshift and premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. To our knowledge, this variant has not been reported in individuals affected with COL3A1-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of COL3A1 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.